Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,743 | 41,084 | 46,169 | 14,349 | N/A |
| Marketable Securities | 3,194 | 4,670 | 6,137 | 5,889 | N/A |
| Receivables | 147 | 1,001 | N/A | N/A | N/A |
| Inventories | 125 | 55 | N/A | N/A | N/A |
| Income taxes - deferred | 1,381 | 1,124 | N/A | N/A | N/A |
| TOTAL | $82,269 | $48,208 | $52,611 | $23,114 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 366 | 98 | 21 | 18 | N/A |
| Investments And Advances | 768 | 0 | 0 | 0 | 0 |
| Intangibles | 113,572 | 64,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 471 | 37 | 36 | 180 | 0 |
| TOTAL | $115,177 | $64,135 | $57 | $198 | $N/A |
| Total Assets | $197,446 | $112,343 | $52,668 | $23,312 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,500 | 5,625 | 1,250 | 625 | N/A |
| Accounts payable and accrued liabilities | 1,382 | 2,307 | 816 | 1,840 | 0 |
| Accrued Expenses | 2,230 | 2,495 | 1,658 | 1,128 | N/A |
| Other current liabilities | 2,686 | 2,629 | 530 | 591 | N/A |
| TOTAL | $14,632 | $16,901 | $5,054 | $4,984 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,442 | 9,310 | 3,691 | 4,310 | N/A |
| Deferred Revenues | 834 | 845 | 800 | 800 | N/A |
| Other Non-Current Liabilities | 1,630 | 1,618 | 87 | 98 | 0 |
| TOTAL | $13,704 | $12,052 | $3,778 | $4,408 | $N/A |
| Total Liabilities | $28,336 | $28,953 | $8,832 | $9,392 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,448 | 29,477 | 23,804 | 21,895 | N/A |
| Common Shares | 29 | 23 | 21 | 1 | N/A |
| Retained earnings | -35,649 | -29,148 | -33,614 | -28,943 | N/A |
| Other shareholders' equity | -576 | 0 | 0 | 41,952 | 0 |
| TOTAL | $169,110 | $83,390 | $43,836 | $13,920 | $N/A |
| Total Liabilities And Equity | $197,446 | $112,343 | $52,668 | $23,312 | $0 |